Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
USChina Trade Rift Persists APEC Meetings Reveal Lingering Disagreements The Pokmon Card Boom Nostalgia Speculation and MillionDollar Sales Attract Crypto Bros and Celebrities UK Navy Deploys to Clear Mines in Strait of Hormuz Amid Geopolitical Tensions SoFi Technologies Solid Recent Quarter Paired With Softer Forward Outlook Surging Gas Prices Disproportionately Impact LowerIncome Households New York Fed Study Indicates Tecogen Inc Q1 2026 Earnings Earnings Beat Estimates Despite Narrower Loss PASG Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Response BBLG Q1 2026 Earnings Narrowed Loss Beats Estimates as Bone Biologics Advances Pipeline CLST Q3 2025 Earnings Catalyst Bancorp Posts 013 EPS Stock Inches Higher Immunome Inc IMNM Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment WhiteHorse Finance WHF Holds Steady Near Key Support Following Modest Uptick Dave Inc DAVE Pushes Higher Nears Key Resistance at 26907 Zevia PBC ZVIA Faces Sharp Decline as Stock Tests Key Support Levels Power Solutions International PSIX Holds Steady Near Support Amid Low Volatility Oil Markets Near Dangerous Tipping Point as USIran Deal Remains Elusive Asia Markets Mixed as South Koreas Kospi Reaches Record High on USIran Peace Hopes Globant SA Faces Class Action Lawsuit Over Alleged Investor Harm Western Digital Emerges as Potential Leader in Data Center Stock Performance for 2026 Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates by 1494 Stock Holds Steady UroGen Pharma Ltd URGN Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Atmos Energy Q1 2026 Earnings Earnings Beat Amid Solid Utility Performance ADAMH Q1 2026 Earnings Senior Notes Trust Beats EPS Estimate by 75 Shares Edge Higher IBRX Q1 2026 Earnings EPS Miss as Biotech Continues PreRevenue Advancement